Anti-Human CD49b (AK7)
CD49b Monoclonal Antibody for FC, ELISA
Host / Isotype
Mouse / IgG1, kappa
Reactivity
Human
Applications
FC, ELISA
Conjugate
Unconjugated
CloneNo.
AK7
Cat no : 65252-1-Ig
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
65252-1-Ig targets CD49b in FC, ELISA applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG1, kappa |
Class | Monoclonal |
Type | Antibody |
Immunogen | Human platelets 相同性解析による交差性が予測される生物種 |
Full Name | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
Calculated molecular weight | 126 kDa |
GenBank accession number | NM_002203 |
Gene symbol | Integrin alpha 2 |
Gene ID (NCBI) | 3673 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
Background Information
CD49b, also known as alpha2 integrin, is a type I transmembrane glycoprotein which forms an adhesion molecule VLA-2 with beta1 integrin. CD49b is a receptor for many (extracellular) matrix and non-matrix molecules (PMID: 23847623). CD49b is expressed on numerous cell types including platelets, activated T cells, B cells, and monocytes. CD49b activation skews NK cell effector function to a phenotype that exhibits elevated IFN-γ production with a concomitant inhibition of motility and cytolytic function (PMID: 32971468, 32762681). The Anti-Human CD49b antibody, clone AK7, is derived from Human platelets.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for CD49b antibody 65252-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |